The Latest Breaking News from Momentum

Although chip industry behemoth NVIDIA Corp. (NVDA) topped analyst estimates in the last reported quarter, would it be wise to invest in the stock amid a slump in semiconductor sales? Let’s look at its financial metrics to gauge its prospects….

The semiconductor industry’s outlook appears optimistic, owing to increasing chip demand across various applications, rising adoption of cutting-edge technology, and lucrative government initiatives and funding. Therefore, chip stocks Intel (INTC), Park Aerospace (PKE), and United Microelectronics (UMC), which are gaining momentum, could be solid portfolio additions this month. Keep reading.

Rachel Reeves said a Labour government would not introduce higher levies on property, capital gains and top earners.

Just over six years ago, a popular movement stymied plans for Budapest to enter a bid to stage the 2024 Olympic Games. Out of that surge against Viktor Orban's government came the Momentum political party.

After its topline decline in the last reported quarter, does ContextLogic (WISH) deserve a place on your watchlist? Let’s look at its financial metrics to gauge its prospects….

fuboTV (FUBO) has a solid topline growth record and has recently raised its guidance. However, its profitability scenario leaves a lot to be desired. Against this backdrop, can FUBO gain momentum in the near term? Let’s look at its financial metrics to gauge its prospects….

As the shipping industry continues to ride a wave of growth driven by escalating global trade demand, fundamentally strong shipping stocks TORM plc (TRMD), International Seaways (INSW), and Navios Maritime Partners (NMM), which have gained steady momentum, might be solid buys. Read more.

Despite macroeconomic uncertainties, the travel industry’s prospects look promising, thanks to pent-up demand for travel. So, investors might consider travel stocks Airbnb (ABNB), Bluegreen Vacations Holding (BVH), and Marcus (MCS), which are well-positioned to maintain their momentum. Read on.

The pharmaceutical industry is growing amid robust demand. Also, given that healthcare stocks are generally thought of as defensive investments, fundamentally strong Johnson & Johnson (JNJ), Novo Nordisk (NVO), and AstraZeneca (AZN) might be profitable buys now. Read on.